PMID- 32869893 OWN - NLM STAT- MEDLINE DCOM- 20210407 LR - 20210407 IS - 1531-4995 (Electronic) IS - 0023-852X (Linking) VI - 131 IP - 4 DP - 2021 Apr TI - Disparities in Mortality from Larynx Cancer: Implications for Reducing Racial Differences. PG - E1147-E1155 LID - 10.1002/lary.29046 [doi] AB - OBJECTIVE: Race predicts overall mortality (OM) of laryngeal squamous cell carcinoma (LSCC) in the United States (US). We assessed whether racial disparities affect cancer-specific mortality (CSM) using the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: Adults with LSCC from 2004 to 2015 were selected. Univariable and multivariable Cox proportional hazards and Fine-Gray competing-risks regression analysis adjusted for clinicodemographic factors defined hazard ratios (aHR). RESULTS: We identified 14,506 patients. The median age was 63 years. Most were male (11,725, 80.8%) and white (11,653, 80.3%), followed by Black (2294, 15.8%). Most had early-stage disease (7544, 52.0%) and received radiotherapy only (4107, 28.3%), followed by chemoradiation (3748, 25.8%). With median follow-up of 60 months, overall 3- and 5-year OM were 34.0% and 43.2%; CSM were 16.0% and 18.9%, respectively. Black patients had higher OM than white patients on univariable (HR 1.35, 95% CI, 1.26-1.44, P < .001) and multivariable (aHR 1.10, 95% CI, 1.02-1.18, P = .011) analyses. Black patients had higher CSM on univariable analysis (HR 1.22, 95% CI, 1.09-1.35, P < .001) but not on multivariable CSM analysis (aHR 1.01, 95% CI, 0.90-1.13, P = .864). On multivariable analysis, year of diagnosis, age, disease site, stage, treatment, nodal metastasis, marital status, education, and geography significantly predicted CSM. CONCLUSION: On multivariable analyses controlling for sociodemographic, clinical, and treatment characteristics, Black and white patients differed in OM but not in CSM. However, Black patients presented with greater proportions of higher stage cancers and sociodemographic factors such as income and marital status that were associated with worse outcomes. Efforts to target sociodemographic disparities may contribute to the mitigation of racial disparities in LSCC. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E1147-E1155, 2021. CI - (c) 2020 American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA). FAU - Chen, Sophia AU - Chen S AUID- ORCID: 0000-0002-9364-3042 AD - Department of Otolaryngology-Head & Neck Surgery, New York University School of Medicine, New York, New York, U.S.A. FAU - Dee, Edward Christopher AU - Dee EC AUID- ORCID: 0000-0001-6119-0889 AD - Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A. AD - Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts, U.S.A. FAU - Muralidhar, Vinayak AU - Muralidhar V AD - Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A. FAU - Nguyen, Paul L AU - Nguyen PL AD - Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A. FAU - Amin, Milan R AU - Amin MR AD - Department of Otolaryngology-Head & Neck Surgery, New York University Langone Health, New York, New York, U.S.A. FAU - Givi, Babak AU - Givi B AD - Department of Otolaryngology-Head & Neck Surgery, New York University Langone Health, New York, New York, U.S.A. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200901 PL - United States TA - Laryngoscope JT - The Laryngoscope JID - 8607378 SB - IM MH - Aged MH - Carcinoma, Squamous Cell/*ethnology/*mortality/therapy MH - Female MH - *Health Status Disparities MH - Humans MH - Laryngeal Neoplasms/*ethnology/*mortality/therapy MH - Male MH - Middle Aged MH - SEER Program MH - United States OTO - NOTNLM OT - Laryngeal cancer, head and neck cancer, racial disparities, overall mortality, cancer-specific mortality EDAT- 2020/09/02 06:00 MHDA- 2021/04/10 06:00 CRDT- 2020/09/02 06:00 PHST- 2020/06/12 00:00 [received] PHST- 2020/07/14 00:00 [revised] PHST- 2020/07/27 00:00 [accepted] PHST- 2020/09/02 06:00 [pubmed] PHST- 2021/04/10 06:00 [medline] PHST- 2020/09/02 06:00 [entrez] AID - 10.1002/lary.29046 [doi] PST - ppublish SO - Laryngoscope. 2021 Apr;131(4):E1147-E1155. doi: 10.1002/lary.29046. Epub 2020 Sep 1.